1. Home
  2. HTCR vs CELU Comparison

HTCR vs CELU Comparison

Compare HTCR & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • CELU
  • Stock Information
  • Founded
  • HTCR 2009
  • CELU 2016
  • Country
  • HTCR Japan
  • CELU United States
  • Employees
  • HTCR N/A
  • CELU N/A
  • Industry
  • HTCR EDP Services
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCR Technology
  • CELU Health Care
  • Exchange
  • HTCR Nasdaq
  • CELU Nasdaq
  • Market Cap
  • HTCR 48.1M
  • CELU 50.4M
  • IPO Year
  • HTCR 2022
  • CELU N/A
  • Fundamental
  • Price
  • HTCR $1.49
  • CELU $2.30
  • Analyst Decision
  • HTCR
  • CELU
  • Analyst Count
  • HTCR 0
  • CELU 0
  • Target Price
  • HTCR N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • HTCR 738.4K
  • CELU 89.6K
  • Earning Date
  • HTCR 11-14-2024
  • CELU 12-06-2024
  • Dividend Yield
  • HTCR 5.37%
  • CELU N/A
  • EPS Growth
  • HTCR N/A
  • CELU N/A
  • EPS
  • HTCR 0.23
  • CELU N/A
  • Revenue
  • HTCR $30,290,930.00
  • CELU $48,200,000.00
  • Revenue This Year
  • HTCR $53.30
  • CELU N/A
  • Revenue Next Year
  • HTCR N/A
  • CELU $233.89
  • P/E Ratio
  • HTCR $6.41
  • CELU N/A
  • Revenue Growth
  • HTCR 47.63
  • CELU 225.94
  • 52 Week Low
  • HTCR $0.45
  • CELU $1.30
  • 52 Week High
  • HTCR $3.38
  • CELU $7.97
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 45.72
  • CELU 52.94
  • Support Level
  • HTCR $1.53
  • CELU $2.04
  • Resistance Level
  • HTCR $1.76
  • CELU $2.39
  • Average True Range (ATR)
  • HTCR 0.39
  • CELU 0.17
  • MACD
  • HTCR -0.06
  • CELU 0.02
  • Stochastic Oscillator
  • HTCR 1.31
  • CELU 70.76

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Share on Social Networks: